Does a Novel Mutagenic Process Target KMT2D Mutation in the Most Common First Event on the Path to Bladder Cancer? (2021)
Attributed to:
Growing a community for health research translation at York
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 79
Parent Publication: EUROPEAN UROLOGY
Issue: 3
ISSN: 0302-2838